STOCK TITAN
  1. Home
  2. Sec-filings
  3. VIR
  4. [144] Vir Biotechnology, Inc. SEC Filing

[144] Vir Biotechnology, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock VIR logo
Vir Biotechnology, Inc.

NASDAQ:VIR

VIR Rankings

#3588 Ranked by Market Cap
N/A Ranked by Dividends

VIR Latest News

May 28, 2025
Vir Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025
May 20, 2025
Vir Biotechnology to Participate in TD Cowen 6th Annual Oncology Innovation Summit
May 12, 2025
Vir Biotechnology to Participate in Bank of America Securities 2025 Healthcare Conference
May 9, 2025
Vir Biotechnology Announces Preliminary 24-Week Post-End of Treatment Data for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B From the MARCH Study
May 7, 2025
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2025 Financial Results

VIR Latest SEC Filings

Jul 17, 2025
[Form 4] Vir Biotechnology, Inc. Insider Trading Activity
Jul 15, 2025
[144] Vir Biotechnology, Inc. SEC Filing
Jul 2, 2025
[Form 4] Vir Biotechnology, Inc. Insider Trading Activity
Jul 1, 2025
[144] Vir Biotechnology, Inc. SEC Filing

VIR Stock Data

819.75M
104.69M
12.01%
76.71%
5.66%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SAN FRANCISCO